In this article, we show for the first time in mice with pancreatic tumors that when CD40 agonist antibody and IL‐15 are combined, they exhibit synergistic effects in terms of enhanced anti‐tumor efficacy resulting in profound increases in long‐term survival with complete cure in the majority of cases. Here, CD40 is linked to pancreatic neoplasm.